TrivarX Limited (ASX:TRI)

Australia flag Australia · Delayed Price · Currency is AUD
0.0080
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM AEST
-68.00%
Market Cap 4.96M
Revenue (ttm) 2.00M
Net Income (ttm) -440.20K
Shares Out 619.83M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 300,750
Average Volume 1,728,692
Open 0.0080
Previous Close 0.0080
Day's Range 0.0080 - 0.0080
52-Week Range 0.0080 - 0.0450
Beta 0.83
RSI 36.04
Earnings Date Aug 28, 2025

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia. [Read more]

Sector Healthcare
Founded 1987
Employees 6
Stock Exchange Australian Securities Exchange
Ticker Symbol TRI
Full Company Profile

Financial Performance

In 2024, TrivarX's revenue was 888,829, a decrease of -7.46% compared to the previous year's 960,451. Losses were -1.43 million, -53.28% less than in 2023.

Financial Statements

News

There is no news available yet.